Cargando…

Challenges and Pitfalls of Using Repeat Spirometry Recordings in Routine Primary Care Data to Measure FEV(1) Decline in a COPD Population

BACKGROUND: Electronic healthcare records (EHR) are increasingly used in epidemiological studies but are often viewed as lacking quality compared to randomised control trials and prospective cohorts. Studies of patients with chronic obstructive pulmonary disease (COPD) often use the rate of forced e...

Descripción completa

Detalles Bibliográficos
Autores principales: Whittaker, Hannah R, Kiddle, Steven J, Quint, Jennifer K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420778/
https://www.ncbi.nlm.nih.gov/pubmed/34512071
http://dx.doi.org/10.2147/POR.S319965
_version_ 1783748948279689216
author Whittaker, Hannah R
Kiddle, Steven J
Quint, Jennifer K
author_facet Whittaker, Hannah R
Kiddle, Steven J
Quint, Jennifer K
author_sort Whittaker, Hannah R
collection PubMed
description BACKGROUND: Electronic healthcare records (EHR) are increasingly used in epidemiological studies but are often viewed as lacking quality compared to randomised control trials and prospective cohorts. Studies of patients with chronic obstructive pulmonary disease (COPD) often use the rate of forced expiratory volume in 1 second (FEV(1)) decline as an outcome; however, its definition and robustness in EHR have not been investigated. We aimed to investigate how the rate of FEV(1) decline differs by the criteria used in an EHR database. METHODS: Clinical Practice Research Datalink and Hospital Episode Statistics were used. Patient populations were defined using 8 sets of criteria around repeated FEV(1) measurements. At a minimum, patients had a diagnosis of COPD, were ≥35 years old, were current or ex-smokers, and had data recorded from 2004. FEV(1) measurements recorded during follow-up were identified. Thereafter, eight populations were defined based on criteria around: i) the exclusion of patients or individual measurements with potential measurement error; ii) minimum number of FEV(1) measurements; iii) minimum time interval between measurements; iv) specific timing of measurements; v) minimum follow-up time; and vi) the use of linked data. For each population, the rate of FEV(1) decline was estimated using mixed linear regression. RESULTS: For 7/8 patient populations, rates of FEV(1) decline (age and sex adjusted) were similar and ranged from −18.7mL/year (95% CI −19.2 to −18.2) to −16.5mL/year (95% CI −17.3 to −15.7). Rates of FEV(1) decline in populations that excluded patients with potential measurement error ranged from −79.4mL/year (95% CI −80.7 to −78.2) to −46.8mL/year (95% CI −47.6 to −46.0). CONCLUSION: FEV(1) decline remained similar in a COPD population regardless of number of FEV(1) measurements, time intervals between measurements, follow-up period, exclusion of specific FEV(1) measurements, and linkage to HES. However, exclusion of individuals with questionable data led to selection bias and faster rates of decline.
format Online
Article
Text
id pubmed-8420778
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-84207782021-09-09 Challenges and Pitfalls of Using Repeat Spirometry Recordings in Routine Primary Care Data to Measure FEV(1) Decline in a COPD Population Whittaker, Hannah R Kiddle, Steven J Quint, Jennifer K Pragmat Obs Res Original Research BACKGROUND: Electronic healthcare records (EHR) are increasingly used in epidemiological studies but are often viewed as lacking quality compared to randomised control trials and prospective cohorts. Studies of patients with chronic obstructive pulmonary disease (COPD) often use the rate of forced expiratory volume in 1 second (FEV(1)) decline as an outcome; however, its definition and robustness in EHR have not been investigated. We aimed to investigate how the rate of FEV(1) decline differs by the criteria used in an EHR database. METHODS: Clinical Practice Research Datalink and Hospital Episode Statistics were used. Patient populations were defined using 8 sets of criteria around repeated FEV(1) measurements. At a minimum, patients had a diagnosis of COPD, were ≥35 years old, were current or ex-smokers, and had data recorded from 2004. FEV(1) measurements recorded during follow-up were identified. Thereafter, eight populations were defined based on criteria around: i) the exclusion of patients or individual measurements with potential measurement error; ii) minimum number of FEV(1) measurements; iii) minimum time interval between measurements; iv) specific timing of measurements; v) minimum follow-up time; and vi) the use of linked data. For each population, the rate of FEV(1) decline was estimated using mixed linear regression. RESULTS: For 7/8 patient populations, rates of FEV(1) decline (age and sex adjusted) were similar and ranged from −18.7mL/year (95% CI −19.2 to −18.2) to −16.5mL/year (95% CI −17.3 to −15.7). Rates of FEV(1) decline in populations that excluded patients with potential measurement error ranged from −79.4mL/year (95% CI −80.7 to −78.2) to −46.8mL/year (95% CI −47.6 to −46.0). CONCLUSION: FEV(1) decline remained similar in a COPD population regardless of number of FEV(1) measurements, time intervals between measurements, follow-up period, exclusion of specific FEV(1) measurements, and linkage to HES. However, exclusion of individuals with questionable data led to selection bias and faster rates of decline. Dove 2021-09-01 /pmc/articles/PMC8420778/ /pubmed/34512071 http://dx.doi.org/10.2147/POR.S319965 Text en © 2021 Whittaker et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Whittaker, Hannah R
Kiddle, Steven J
Quint, Jennifer K
Challenges and Pitfalls of Using Repeat Spirometry Recordings in Routine Primary Care Data to Measure FEV(1) Decline in a COPD Population
title Challenges and Pitfalls of Using Repeat Spirometry Recordings in Routine Primary Care Data to Measure FEV(1) Decline in a COPD Population
title_full Challenges and Pitfalls of Using Repeat Spirometry Recordings in Routine Primary Care Data to Measure FEV(1) Decline in a COPD Population
title_fullStr Challenges and Pitfalls of Using Repeat Spirometry Recordings in Routine Primary Care Data to Measure FEV(1) Decline in a COPD Population
title_full_unstemmed Challenges and Pitfalls of Using Repeat Spirometry Recordings in Routine Primary Care Data to Measure FEV(1) Decline in a COPD Population
title_short Challenges and Pitfalls of Using Repeat Spirometry Recordings in Routine Primary Care Data to Measure FEV(1) Decline in a COPD Population
title_sort challenges and pitfalls of using repeat spirometry recordings in routine primary care data to measure fev(1) decline in a copd population
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420778/
https://www.ncbi.nlm.nih.gov/pubmed/34512071
http://dx.doi.org/10.2147/POR.S319965
work_keys_str_mv AT whittakerhannahr challengesandpitfallsofusingrepeatspirometryrecordingsinroutineprimarycaredatatomeasurefev1declineinacopdpopulation
AT kiddlestevenj challengesandpitfallsofusingrepeatspirometryrecordingsinroutineprimarycaredatatomeasurefev1declineinacopdpopulation
AT quintjenniferk challengesandpitfallsofusingrepeatspirometryrecordingsinroutineprimarycaredatatomeasurefev1declineinacopdpopulation